Substance
IXEKIZUMAB
Global reference: every product and company linked to this substance.
- cas: 1143503-69-8
- ncit: C174646
- rxnorm: 1745099
- unii: BTY153760O
ixekizumab [INN] · IXEKIZUMAB [JAN] · IXEKIZUMAB [USAN] · Ixekizumab [WHO-DD] · LY-2439821 · LY2439821 · TALTZ
Revenue by product (2)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| ELI LILLY AND COMPANY COMMON STOCK | TALTZ | Q2 2026 | $856.0M |
| ELI LILLY AND COMPANY COMMON STOCK | TALTZ | Q2 2026 | $856.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- TALTZ · ELI LILLY AND COMPANY COMMON STOCK
- TALTZ · ELI LILLY AND COMPANY COMMON STOCK